Skip to content

MEDICINOVA, INC.: 10-Q filed 2012-08-09

What MEDICINOVA, INC. reported in its quarterly report filed 2012-08-09 (fiscal Q2 2012): 34 published measures, 99 facts as tagged in accession 0001193125-12-347932.

This filing

Form
10-Q (quarterly report)
Filed
2012-08-09
Fiscal period
fiscal Q2 2012
Accession
0001193125-12-347932 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEDICINOVA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-06-3023,034,807USD
At 2011-12-3130,787,330USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-06-305,163,577USD
At 2011-12-317,289,784USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-06-3017,871,230USD
At 2011-12-3123,497,546USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-06-307,258,530USD
At 2011-12-3115,093,124USD
At 2011-06-3011,921,990USD
At 2010-12-3128,252,204USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-2,281,350USD91
2012-01-01 to 2012-06-30-6,148,573USD182
2000-09-26 to 2012-06-30-260,057,934USD4296
2011-04-01 to 2011-06-30-4,681,348USD91
2011-01-01 to 2011-06-30-10,337,078USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-7,270,877USD182
2000-09-26 to 2012-06-30-205,118,910USD4296
2011-01-01 to 2011-06-30-9,384,326USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-06-3049,336USD182
2000-09-26 to 2012-06-302,326,926USD4296

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-04-01 to 2012-06-30493,623USD91
2012-01-01 to 2012-06-30684,797USD182
2000-09-26 to 2012-06-302,243,024USD4296

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-06-30165,619USD182
2000-09-26 to 2012-06-30217,244,832USD4296
2011-01-01 to 2011-06-30-6,945,888USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-729,336USD182
2000-09-26 to 2012-06-30-4,867,392USD4296

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-06-30-291,421,056USD
At 2011-12-31-285,272,483USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2000-09-26 to 2012-06-3064,817USD4296

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-06-3062,209USD
At 2011-12-3129,425USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-06-30361,521USD182
2000-09-26 to 2012-06-3050,042,802USD4296
2011-01-01 to 2011-06-30333,110USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-2,288,204USD91
2012-01-01 to 2012-06-30-6,161,463USD182
2000-09-26 to 2012-06-30-273,425,744USD4296
2011-04-01 to 2011-06-30-3,722,306USD91
2011-01-01 to 2011-06-30-8,698,680USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-06-307,892,958USD
At 2011-12-3115,707,664USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2000-09-26 to 2012-06-303,605,818USD4296
2011-04-01 to 2011-06-30943,745USD91
2011-01-01 to 2011-06-301,596,132USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-06-303,207,577USD
At 2011-12-313,697,294USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-06-30440,107USD
At 2011-12-31718,882USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2012-06-309,600,241USD
At 2011-12-319,600,241USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-27,889USD182
2000-09-26 to 2012-06-301,195,598USD4296
2011-01-01 to 2011-06-30-4,005USD181

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-04-01 to 2012-06-302,781,827USD91
2012-01-01 to 2012-06-306,846,260USD182
2000-09-26 to 2012-06-30275,668,768USD4296
2011-04-01 to 2011-06-303,722,306USD91
2011-01-01 to 2011-06-308,698,680USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2000-09-26 to 2012-06-301,258,421USD4296

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-04-01 to 2012-06-301,483,939USD91
2012-01-01 to 2012-06-303,362,400USD182
2000-09-26 to 2012-06-30165,403,963USD4296
2011-04-01 to 2011-06-302,040,060USD91
2011-01-01 to 2011-06-304,663,958USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-06-3016,163,565shares
At 2011-12-3116,088,015shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-06-30310,497,442USD
At 2011-12-31309,998,251USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-06-30-61,728USD
At 2011-12-31-56,845USD
At 2011-06-30-61,045USD
At 2010-12-31-55,702USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-06-30742,950USD
At 2011-12-311,515,815USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-06-30634,428USD
At 2011-12-31614,540USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-2,281,350USD91
2012-01-01 to 2012-06-30-6,148,573USD182
2000-09-26 to 2012-06-30-259,993,117USD4296
2011-04-01 to 2011-06-30-4,681,348USD91
2011-01-01 to 2011-06-30-10,337,078USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-2,281,350USD91
2012-01-01 to 2012-06-30-6,148,573USD182
2000-09-26 to 2012-06-30-291,421,056USD4296
2011-04-01 to 2011-06-30-4,681,348USD91
2011-01-01 to 2011-06-30-10,337,078USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-301,297,888USD91
2012-01-01 to 2012-06-303,483,860USD182
2000-09-26 to 2012-06-30109,006,384USD4296
2011-04-01 to 2011-06-301,682,246USD91
2011-01-01 to 2011-06-304,034,722USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-06-3016,552USD182
2000-09-26 to 2012-06-301,961,976USD4296
2011-01-01 to 2011-06-3023,906USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-06-30137,730USD182
2000-09-26 to 2012-06-30131,316,352USD4296
2011-01-01 to 2011-06-307,973,634USD181

Inspect the source

Entity
MEDICINOVA, INC. / CIK 0001226616
Captured
2026-09-20T07:46:14.294Z
SEC response SHA-256
2ee4e761c5c78942e5c8408ca3fc8acae481ff5fcfadf88ffba53700bd842714

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001226616.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))